JOANNE SCHILPEROORT: Open Payments
NPI 1568796894 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $204 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $152 |
| Amgen Inc. | 8 | $151 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Novo Nordisk Inc | 3 | $72 |
| Abbott Laboratories | 1 | $57 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| PFIZER INC. | 1 | $36 |
| Exact Sciences Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: VERQUVO, REPATHA, LEQVIO, JARDIANCE, Wegovy, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, AMVUTTRA, VYNDAQEL.
Industry payments across CA — which companies pay providers there.
